American Lion Holdings

American Lion Holdings is a U.S. private company that appears to operate primarily as a commercial distributor in healthcare rather than as a therapeutics developer. Publicly available evidence ties the company to an exclusive 2023 agreement to commercialize Alercell surgical operating tables and related equipment for hospitals and surgical centers in several U.S. East Coast states. Available records indicate the entity is organized as a limited liability company in New York and remains active. There is no clear evidence that the company runs a drug-development pipeline, proprietary therapeutic platform, or clinical-stage biotech programs. As a result, American Lion Holdings is best characterized as a small healthcare commercialization and distribution business focused on medical equipment.